Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Januar 2026 11:16 ET | Quelle: Equity Insider

The Quality Premium: Why High-Grade Gold Districts are Driving a 2026 Institutional Re-Rating

VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- EquityInsider.com News Commentary — The global gold sector enters 2026 confronting a structural scarcity as geological complexity and...
15. Januar 2026 09:00 ET | Quelle: Equity Insider

The $1.8T Energy Sprint: Why America is Betting Big on Strategic Mineral Platforms

VANCOUVER, British Columbia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — The global clean energy infrastructure market is on a collision course with a $1.8 trillion valuation...
14. Januar 2026 10:39 ET | Quelle: USA News Group

The $185B Cancer Surge: Why the FDA's Fast-Track Pivot is Scaling a New Immunotherapy Era

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global immuno-oncology market is set to explode from its current $35 billion level to a massive...
14. Januar 2026 10:15 ET | Quelle: USA News Group

THE SOVEREIGN MANDATE: 5 Stocks Securing the 2026 Choke Points

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com Market Intelligence Brief – The era of abundance has reached its limit. The speculative fever of the last decade has...
14. Januar 2026 08:30 ET | Quelle: Equity Insider

The AI Nuclear Acceleration: Why Big Tech is Fueling a U.S. Uranium Gold Rush

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – After decades of flat demand, U.S. electricity generation is finally accelerating, with growth...
12. Januar 2026 10:14 ET | Quelle: Equity Insider

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The biotechnology sector is entering a high-stakes survival sprint as major pharmaceutical giants...
08. Januar 2026 12:26 ET | Quelle: USA News Group

The Q-Day Gold Rush: Why This $30B Tech Shift is the Next Defensive Supercycle

VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) -- USA News Group News Commentary – The race to survive "Q-Day" is on, and it is triggering a massive $30 billion tech migration. The...
07. Januar 2026 12:15 ET | Quelle: Equity Insider

THE CHOKE POINT: 5 Assets That Control the Bottleneck

Issued on behalf of GoldHaven Resources Corp. VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Equity Insider Market Intelligence Brief – The era of abundance is over. The digital...
07. Januar 2026 10:15 ET | Quelle: Equity Insider

The $35B Secret: Why 'Decision Speed' is the New Gold Rush in Defense

VANCOUVER, British Columbia, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary – The modern battlefield is being rewritten. It is no longer just about who has the biggest guns, but...
06. Januar 2026 11:16 ET | Quelle: Equity Insider

Strategic Minerals Surge: Defense Spending Fuels Critical Metals Race

VANCOUVER, British Columbia, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary — Federal priorities are expanding beyond rare earths to include tungsten and antimony as Washington...

Nächste Seite